Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. (Q50556628)
Jump to navigation
Jump to search
scientific article published on 19 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. |
scientific article published on 19 April 2011 |
Statements
Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. (English)
1 reference
1 reference
Eiji Tanaka
1 reference
Takeji Umemura
1 reference
Yoshihiko Katsuyama
1 reference
Kaname Yoshizawa
1 reference
Satoru Joshita
1 reference
Suguru Yoneda
1 reference
Tetsuya Ichijo
1 reference
Nagano Interferon Treatment Research Group
1 reference
Akihiro Matsumoto
1 reference
19 April 2011
1 reference
41
1 reference
6
1 reference
587-593
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference